SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-013535
Filing Date
2018-05-15
Accepted
2018-05-15 09:09:46
Documents
56
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 MARCH 31, 10-Q arpo-10q_20180331.htm 10-Q 898487
2 EX-31.1 arpo-ex311_6.htm EX-31.1 20043
3 EX-31.2 arpo-ex312_7.htm EX-31.2 21257
4 EX-32.1 arpo-ex321_8.htm EX-32.1 10528
5 EX-32.2 arpo-ex322_9.htm EX-32.2 11733
  Complete submission text file 0001564590-18-013535.txt   3890490

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arpo-20180331.xml EX-101.INS 789515
7 XBRL TAXONOMY EXTENSION SCHEMA arpo-20180331.xsd EX-101.SCH 32902
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arpo-20180331_cal.xml EX-101.CAL 27633
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arpo-20180331_def.xml EX-101.DEF 93921
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arpo-20180331_lab.xml EX-101.LAB 267940
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arpo-20180331_pre.xml EX-101.PRE 209041
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53057 | Film No.: 18833432
SIC: 2834 Pharmaceutical Preparations